✦ LIBER ✦

Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

✍ Scribed by Charles L Sawyers

Book ID: 117211269
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 997 KB
Volume: 38
Category: Article
ISSN: 1532-8686
DOI: 10.1016/s0037-1963(01)90113-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dual tyrosine kinase inhibitors in chron

Dual tyrosine kinase inhibitors in chronic myeloid leukemia

✍ Martinelli, G; Soverini, S; Rosti, G; Baccarani, M 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 322 KB

Patient adherence to tyrosine kinase inh

Patient adherence to tyrosine kinase inhibitor therapy in chronic myeloid leukemia

✍ Elias J. Jabbour; Hagop Kantarjian; Lina Eliasson; A. Megan Cornelison; David Ma 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 833 KB

PCN30 COSTS RELATED TO ADVERSE EVENTS IN

✍ N Newton; MM Goetghebeur; KE Ouagari 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Molecular monitoring in chronic myeloid

Molecular monitoring in chronic myeloid leukemia : Response to tyrosine kinase inhibitors and prognostic implications

✍ Elias Jabbour; Jorge E. Cortes; Hagop M. Kantarjian 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

## Abstract The majority of patients with chronic‐phase (CP) chronic myeloid leukemia (CML) who are treated with Bcr‐Abl tyrosine kinase inhibitors such as imatinib and dasatinib achieve cytogenetic disease remission (ie, Philadelphia chromosome‐positive cells undetectable by cytogenetic evaluation

SP 108 Resistance to tyrosine kinase inh

SP 108 Resistance to tyrosine kinase inhibitors in chronic myeloid leukemia

✍ T. Lion 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Adherence to oral tyrosine kinase inhibi

Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia

✍ Adam Gater; Louise Heron; Linda Abetz-Webb; John Coombs; Jeff Simmons; François 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 834 KB